Free daily briefing on global business news.
The telehealth company posted a net loss of $86.3 million in the second quarter while raising its full-year revenue outlook to $3.1–$3.3 billion
Hims & Hers Health reported a net loss of $86.3 million in the second quarter of 2026, swinging from net income of $42.5 million in the same period a year earlier, even as revenue climbed 38% to $753.2 million.
The company raised its full-year 2026 revenue guidance to a range of $3.1 billion to $3.3 billion, up from a prior target of $2.8 billion to $3 billion, the company said. It also updated its adjusted EBITDA guidance to a range of $275 million to $325 million. Analysts had expected full-year revenue of $2.93 billion, according to Benzinga.
Quarterly revenue of $753.2 million beat analyst expectations of $699.9 million. Domestic revenue grew 16% year over year to $621.8 million, while international revenue reached $131.4 million, up more than 17-fold from $7.5 million in the year-earlier quarter, a jump the company attributed to its Eucalyptus acquisition closing in June. Subscriber count rose 19% year over year to nearly 2.9 million, and monthly revenue per average subscriber increased 21% to $92.
